Journals / Turkish Journal of Hematology / 2012 / Cilt: 29 - Sayı: 4

Von Willebrand hastalığı nın moleküler genetiği

The molecular genetics of von willebrand disease

Pages
313–324
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The present review aimed to provide a summary of the current literature on the molecular genetics of vWD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Quantitative and/or qualitative deficiency of von Willebrand factor (vWF) is associated with the most common inherited bleeding disease von Willebrand disease (vWD). vWD is a complex disease with clinical and genetic heterogeneity.
📊
Key Findings & Data:Some vWF gene mutations are associated with the affected vWF biosynthesis and multimerization, whereas others are associated with increased clearance and functional impairment.
💡
Conclusion & Impact:The present review aimed to provide a summary of the current literature on the molecular genetics of vWD.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Quantitative and/or qualitative deficiency of von Willebrand factor (vWF) is associated with the most common inherited bleeding disease von Willebrand disease (vWD). vWD is a complex disease with clinical and genetic heterogeneity. Incomplete penetrance and variable expression due to genetic and environmental factors contribute to its complexity. vWD also has a complex molecular pathogenesis. Some vWF gene mutations are associated with the affected vWF biosynthesis and multimerization, whereas others are associated with increased clearance and functional impairment. Moreover, in addition to a particular mutation, type O blood may result in the more severe phenotype. The present review aimed to provide a summary of the current literature on the molecular genetics of vWD.

Özet

Von Willebrand Faktöründe (vWF) görülen kantitatif azalma veya kalitatif bozukluklar bir kanama diyatezi olan ve oldukça sık rastlanan von Willebrand Hastalığının (VWH) oluşumuna neden olur. VWH klinik ve genetik heterojenite gösteren karmaşık bir hastalıktır. Genetik ve çevresel nedenlere ikincil eksik penetrans ve VWF düzeyinde olan değişiklikler olması VWHnın karmaşık bir yapı göstermesine neden olan faktörlerdir. VWF genindeki mutasyonlardan bazıları biyosentezi ve multimerizasyonu etkilerken, diğer mutasyonlar vWFnin dolaşımdan daha erken uzaklaştırılmasına neden olarak fonksiyonunu etkiler. Belirli bir mutasyon ile birlikte kan grubunun da O olması fenotipin daha ağır olmasına neden olabilir. Bu derlemenin amacı vWHnın moleküler genetiği ile ilgili güncel yayınları inceleyerek onların bir özetini yapmaktır.

🔖

Cite This Article

BERBER, E. (2012). Von Willebrand hastalığı nın moleküler genetiği. Turkish Journal of Hematology, Cilt: 29 - Sayı: 4, 313–324. https://ajindex.com/articles/412645

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Lillicrap D. Genotype/phenotype association in von Willebrand disease: Is the glass half ful lor empty?. J Thromb and Haemost 2009; 7:65-70
  2. Von Willebrand EA. Finska Lakarasallsk Hand 1926; 68:87
  3. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood 1987; 69:454-459
  4. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123:893-898
  5. Bloom AL. von Willebrand factor: Clinical features of inherited and acquired disorders. Mayo Clin Proc 1991; 66:743-751
  6. Rodeghiero F, Castaman G, Tosetto A. Optimizing treatment of von Willebrand disease by using phenotypic and molecular data. Hematology Am Soc Hematol Educ Program 2009; 113-123
  7. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, Federici AB. Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4:2103-2114
  8. Ruggeri ZM. Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 2001; 14:257-279
  9. Wagner DD. Cell Biology of Von Willebrand factor. Annu Rev Cell Biol. 1990; 6:217-246
  10. Sadler JE. Von Willebrand factor assembly and secretion. J Thromb Haemost 2009; 7:24-27
  11. Verweij CL, Diergaarde PJ, Hart M, Pannekoek H. Full- length von Willebrand factor (vWF) encodes a highly repetitive protein considerably larger than the mature vWF subunit. EMBO J 1986; 5:1839-1846
  12. Lowenstein CJ, Morrell CN, Yamakuchi M. Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med 2005; 15:302-308
  13. Rondaij MG, Bierings R, Kragt A, van Mourik JA, Voorberg J. Arterioscler Dynamics and plasticity of Weibel-Palade Bodies in endothelial cells. Arterioscler Thromb Vasc Biol 2006; 26:1002-1007
  14. Giblin JP, Hewlett LJ, Hannah MJ. Basal secretion of von Willebrand factor from human endothelial cells. Blood 2008; 112:957-964
  15. Bonthron DT, Handin RI, Kaufman RJ, Wasley LC, Orr EC, Mitsock LM, Ewenstein B, Loscalzo J, Ginsburg D, Orkin SH. Structure of pre-pro von Willebrand factor and its expression in heterologous cells. Nature 1986; 324:270- 273
  16. Wang JW, Eikenboom